122 related articles for article (PubMed ID: 31088935)
1. Complete Resolution of Tumoral Calcinosis in a Patient on Peritoneal Dialysis with Cinacalcet.
Hayat A
Perit Dial Int; 2019; 39(3):292-293. PubMed ID: 31088935
[No Abstract] [Full Text] [Related]
2. Uraemic tumoral calcinosis in a peritoneal dialysis patient.
Zhou H; Yang M; Zou Y
Intern Med J; 2018 Dec; 48(12):1544-1546. PubMed ID: 30517983
[No Abstract] [Full Text] [Related]
3. Regression of tumoral calcinosis after the appropriate control of a deranged mineral and bone metabolism, in conjugation with cinacalcet hydrochloride treatment, in a chronic hemodialysis patient.
Yamada S; Tsuruya K; Kitazono T
Ther Apher Dial; 2013 Jun; 17(3):348-9. PubMed ID: 23735152
[No Abstract] [Full Text] [Related]
4. Outcomes of cinacalcet withdrawal in Australian dialysis patients.
Ruderman I; Holt SG; Kirkland GS; Maslen S; Hawley CM; Oliver V; Krishnasamy R; Gray NA; Talaulikar GS; Nelson CL; Rajaram Y; Gock H; Au E; Elder GJ; Mainra R; Toussaint ND
Intern Med J; 2019 Jan; 49(1):48-54. PubMed ID: 29992701
[TBL] [Abstract][Full Text] [Related]
5. Dramatic Regression of Parathyroid Gland Swelling After Conversion of Calcimimetic Medication From Cinacalcet to Etelcalcetide.
Yoshimura K; Funakoshi Y; Terawaki H
Ther Apher Dial; 2018 Oct; 22(5):553-554. PubMed ID: 29927050
[No Abstract] [Full Text] [Related]
6. Uraemic tumoural calcinosis.
Chow KM; Szeto CC; Wang AY; Li PK
Nephrol Dial Transplant; 2004 Feb; 19(2):505-6. PubMed ID: 14736986
[No Abstract] [Full Text] [Related]
7. Withdrawal of cinacalcet at the time of renal transplantation is not a risk factor for allograft calcifications in the early posttransplantation period.
Paschoalin RP; Torregrosa JV; Barros X; Durán CE; Soler M; Campistol JM
Transplant Proc; 2012 Oct; 44(8):2379-80. PubMed ID: 23026598
[TBL] [Abstract][Full Text] [Related]
8. A case of uremia-associated pleural effusion in a peritoneal dialysis patient.
Krishnan M; Choi M
Semin Dial; 2001; 14(3):223-7. PubMed ID: 11422930
[TBL] [Abstract][Full Text] [Related]
9. Effects of calcimimetics on long-term outcomes in dialysis patients: literature review and Bayesian meta-analysis.
Lozano-Ortega G; Waser N; Bensink ME; Goring S; Bennett H; Block GA; Chertow GM; Trotman ML; Cooper K; Levy AR; Belozeroff V
J Comp Eff Res; 2018 Jul; 7(7):693-707. PubMed ID: 29762046
[TBL] [Abstract][Full Text] [Related]
10. Cinacalcet as rescue therapy for refractory hyperparathyroidism in young children with advanced chronic kidney disease.
Arenas Morales AJ; DeFreitas MJ; Katsoufis CP; Seeherunvong W; Chandar J; Zilleruelo G; Freundlich M; Abitbol CL
Pediatr Nephrol; 2019 Jan; 34(1):129-135. PubMed ID: 30203374
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal changes in bone and mineral metabolism after cessation of cinacalcet in dialysis patients with secondary hyperparathyroidism.
Ruderman I; Smith ER; Toussaint ND; Hewitson TD; Holt SG
BMC Nephrol; 2018 May; 19(1):113. PubMed ID: 29764395
[TBL] [Abstract][Full Text] [Related]
12. Mass-like and extensive secondary tumoral calcinosis in the neck and body of a patient on peritoneal dialysis.
Shpilberg KA; Blowe SE; Som PM
Clin Imaging; 2013; 37(5):972-5. PubMed ID: 23751266
[TBL] [Abstract][Full Text] [Related]
13. Primary hyperparathyroidism in pregnancy treated with cinacalcet: a case report.
Gonzalo García I; Robles Fradejas M; Martín Macías MLA; Biain Ciganda A; Bustinza Beaskoetxea Z; Ruiz Pérez E; Fernández Matia G; Martínez Guisasola J
J Obstet Gynaecol; 2018 Jan; 38(1):132-134. PubMed ID: 28760052
[No Abstract] [Full Text] [Related]
14. Short- and middle-term continuous use of cinacalcet in children on peritoneal dialysis.
Dotis J; Printza N; Ghogha C; Papachristou F
J Pediatr Endocrinol Metab; 2013; 26(1-2):39-43. PubMed ID: 23382299
[TBL] [Abstract][Full Text] [Related]
15. Rapid progression of nodular calcification documented by intra-coronary imaging devices and histology.
Tsuchiya H; Nakano A; Hasegawa A; Nakazawa G; Negishi K
Eur Heart J Cardiovasc Imaging; 2016 Aug; 17(8):899. PubMed ID: 27126321
[No Abstract] [Full Text] [Related]
16. Cinacalcet as an alternative to phosphate therapy in X-linked hypophosphataemic rickets.
Alon US; Jarka D; Monachino PJ; Sebestyen VanSickle J; Srivastava T
Clin Endocrinol (Oxf); 2017 Jul; 87(1):114-116. PubMed ID: 28382624
[No Abstract] [Full Text] [Related]
17. Sudden increase in "urine" output in a peritoneal dialysis patient.
Cornelis T; Bargman JM
Perit Dial Int; 2010; 30(5):574-6. PubMed ID: 20829553
[No Abstract] [Full Text] [Related]
18. Phase 2b study of evocalcet (KHK7580), a novel calcimimetic, in Japanese patients with secondary hyperparathyroidism undergoing hemodialysis: A randomized, double-blind, placebo-controlled, dose-finding study.
Akizawa T; Shimazaki R; Fukagawa M;
PLoS One; 2018; 13(10):e0204896. PubMed ID: 30379826
[TBL] [Abstract][Full Text] [Related]
19. Gastric Electrical Stimulation Improves Symptoms of Diabetic Gastroparesis in Patients on Peritoneal Dialysis-2 Case Reports.
Majanović SK; Zelić M; Belančić A; Licul V; Vujičić B; Girotto N; Štimac D
Perit Dial Int; 2018; 38(6):458-462. PubMed ID: 30413639
[TBL] [Abstract][Full Text] [Related]
20. Dialysis and the diabetic patient: basic description and problems.
Tatum-Johnson HK
Diabetes Educ; 1981; 7(2):11-6. PubMed ID: 6912101
[No Abstract] [Full Text] [Related]
[Next] [New Search]
